Market Overview The cervical cancer diagnostic market encompasses an extensive array of medical testing technologies, instruments, and assays designed to identify pre-cancerous lesions and human papillomavirus (HPV) infections before they advance into invasive malignancies. Historically reliant on conventional Pap smears, the market has transformed into a sophisticated molecular landscape...